Antiinflammatory consequences of 5-lipoxygenase inhibition.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001091:Arachidonate Lipoxygenases / Q000037:antagonists & inhibitors*; D016718:Arachidonic Acid; D001095:Arachidonic Acids; D002633:Chemotaxis / Q000187:drug effects; D003877:Dermatitis, Contact / Q000188:drug therapy / Q000209:etiology; D004139:Dinitrofluorobenzene / Q000276:immunology; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007249:Inflammation / Q000188:drug therapy / Q000201:enzymology; D016859:Lipoxygenase Inhibitors; D051379:Mice; D051381:Rats
D000893:Anti-Inflammatory Agents; D001095:Arachidonic Acids; D016859:Lipoxygenase Inhibitors; D016718:Arachidonic Acid; D004139:Dinitrofluorobenzene; D001091:Arachidonate Lipoxygenases